Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNIP1 overlapping transcript 1 (KCNIP1-OT1), also known as CTD-2270F17.1, is a long non-coding RNA transcribed from a region overlapping or adjacent to the KCNIP1 gene on human chromosome 5. It is annotated in genomic resources but has no established or well-characterized physiological or pathological function in the current biomedical literature, nor is it considered a protein, receptor, or therapeutic target. Its presence is primarily noted in datasets cataloguing long non-coding RNAs, and studies instead focus on the protein-coding gene KCNIP1, which is involved in cardiac ion channel regulation and atrial fibrillation susceptibility. There is no documented evidence of KCNIP1-OT1 being druggable, modulating disease, or serving as a clinical biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KCNIP1 overlapping transcript 1 (KCNIP1-OT1).